FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 329:498-499 August 12, 1993 Number 7 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Only two decades ago, the treatment of patients with recurrent ventricular tachycardia and fibrillation was entirely empirical and relied exclusively on drug therapy. The proarrhythmic effects of drug treatment and the possibility that such treatment could be deleterious were virtually unknown. The clinical techniques of cardiac electrophysiology and electrocardiographic (Holter) monitoring, just beginning to be used in the 1960s, were to change that approach beyond all recognition. With prolonged electrocardiographic monitoring,¹ important data could be obtained about cardiac arrhythmias in a variety of conditions. Most important, such noninvasive monitoring became a method of assessing the effects of antiarrhythmic drugs on . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Adamson, P. B., Vanoli, E., Hull, S. S., Foreman, R. D., Schwartz, P. J. (1998). Antifibrillatory efficacy of ersentilide, a novel {beta}-adrenergic and Ikr blocker, in conscious dogs with a healed myocardial infarction. Cardiovasc Res 40: 56-63 [Abstract] [Full Text]  
• Zipes, D. P. (1995). Are Implantable Cardioverter-Defibrillators Better Than Conventional Antiarrhythmic Drugs for Survivors of Cardiac Arrest?. Circulation 91: 2115-2117 [Full Text]  
• Gettes, L. S. (1995). ESVEM and the Hazards of Clinical Trials. Circulation 91: 1908-1909 [Full Text]  
• Reiter, M. J., Mann, D. E., Reiffel, J. E., Hahn, E., Hartz, V. (1995). Significance and Incidence of Concordance of Drug Efficacy Predictions by Holter Monitoring and Electrophysiological Study in the ESVEM Trial. Circulation 91: 1988-1995 [Abstract] [Full Text]  
• McMurray, J., Rankin, A. (1994). Recent Advances: Cardiology II: Treatment of heart failure and atrial fibrillation and arrhythmias. BMJ 309: 1631-1635 [Full Text]  
• Roden, D. M. (1994). Risks and Benefits of Antiarrhythmic Therapy. NEJM 331: 785-791 [Full Text]  
• Hohnloser, S. H., Woosley, R. L. (1994). Sotalol. NEJM 331: 31-38 [Full Text]